PERIPHERAL‐TYPE BENZODIAZEPINE BINDING IN ALZHEIMER DISEASE

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Alzheimer Disease and Associated Disorders

• Publication date

  1988-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00002093-198802040-00001PMID 2848549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease

  2023cites this paper
• Osteopontin/secreted phosphoprotein‐1 harnesses glial‐, immune‐, and neuronal cell ligand‐receptor interactions to sense and regulate acute and chronic neuroinflammation

  2022cites this paper
• Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies

  2020cites this paper
• PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding

  2018cites this paper
• Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111

  2017cites this paper
• Participation of perforin in mediating dopaminergic neuron loss in MPTP-induced Parkinson's disease in mice.

  2017cites this paper
• Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

  2016cites this paper
• Molecular imaging of neuroinflammation in Alzheimer’s disease

  2015cites this paper
• Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair

  2015cites this paper
• Synthesis of [¹¹C]PBR170, a novel imidazopyridine, for imaging the translocator protein with PET.

  2014influential citation
• Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease

  2013cites this paper
• Persistent region-dependent neuroinflammation, NMDA receptor loss and atrophy in an animal model of penetrating brain injury.

  2012cites this paper
• Automated radiosynthesis of [18F]PBR111 and [18F]PBR102 using the Tracerlab FXFN and Tracerlab MXFDG module for imaging the peripheral benzodiazepine receptor with PET.

  2012cites this paper
• Inflammation and adaptive immunity in Parkinson's disease.

  2012influential citation
• Regional sensitivity to neuroinflammation: In vivo and in vitro studies

  2011cites this paper
• Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases

  2010cites this paper
• Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states.

  2009cites this paper
• Chapter 2 Steroid Metabolism in Glial Cells

  2008cites this paper
• Steroid Metabolism in Glial Cells

  2008cites this paper
• Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders.

  2006cites this paper
• ETUDE DE L'AMPLIFICATION DE LA NEURODEGENERESCENCE EXCITOTOXIQUE PAR UNE DYSFONCTION MITOCHONDRIALE : IMPLICATIONS POUR LA MALADIE DE HUNTINGTON

  2006cites this paper
• Steroids and glial cell function

  2006cites this paper
• Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics

  2005cites this paper
• Ligands for peripheral benzodiazepine binding sites in glial cells.

  2005cites this paper
• Chronological study of peripheral benzodiazepine binding sites in the rat brain stab wounds using [3H] PK-11195 as a marker for gliosis

  2005cites this paper
• Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients

  2005cites this paper
• Peripheral benzodiazepine receptor and its clinical targeting.

  2004cites this paper
• Region‐selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain

  2002cites this paper
• Effects of Ginkgo biloba extract (EGb 761) on gene expression: Possible relevance to neurological disorders and age‐associated cognitive impairment

  2002influential citation
• Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells

  2002cites this paper
• Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis.

  2001cites this paper
• Up‐regulation of the peripheral‐type benzodiazepine receptor expression and [3H]PK11195 binding in gerbil hippocampus after transient forebrain ischemia

  2001cites this paper
• Peripheral‐type benzodiazepine receptors: Their implication in brain disease

  2000cites this paper
• Inhibitory action of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxam ide (PK 11195) on some mononuclear phagocyte functions.

  2000cites this paper
• Pathways of Neurosteroid Biosynthesis in Cell Lines from Human Brain

  2000cites this paper
• Location-dependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesis.

  2000cites this paper
• Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus.

  2000cites this paper
• A Unifying Hypothesis of Alzheimer's Disease. IV. Causation and Sequence of Events

  2000cites this paper
• Enigma of the peripheral benzodiazepine receptor.

  1999cites this paper
• The peripheral benzodiazepine receptor ligand PK 11195 inhibits arthritis in the MRL-lpr mouse model.

  1999cites this paper
• T-lymphocyte peripheral-type benzodiazepine binding in parkinsonian patients.

  1997cites this paper
• Platelet and lymphocyte benzodiazepine binding in patients with Alzheimer's disease.

  1997cites this paper
• Increased expression of peripheral benzodiazepine receptors in the facial nucleus following motor neuron axotomy.

  1997cites this paper
• T lymphocyte benzodiazepine binding is reduced in demented patients.

  1997cites this paper
• PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia

  1997cites this paper
• The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.

  1996cites this paper
• New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia

  1996cites this paper
• Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat

  1995cites this paper
• Macrophage and Astrocyte Populations in Relation to [3H]PK 11195 Binding in Rat Cerebral Cortex following a Local Ischaemic Lesion

  1991cites this paper
• In Vivo Binding to Peripheral Benzodiazepine Binding Sites in Lesioned Rat Brain: Comparison Between [3H]PK11195 and [18F]PK14105 as Markers for Neuronal Damage

  1990cites this paper
• Unraveling prion diseases through molecular genetics.

  1989cites this paper